GlyCardial Diagnostics believes it has the technology to prevent premature myocardial infarctions, 80% of which are preventable. Barcelona-based GlyCardial Diagnostics is…
AstraZeneca will work with Moderna Therapeutics to bring together to the market an mRNA version of Novartis' failed heart failure drug Serelaxin. AstraZeneca has…